SB

Shelly Batra

Active Director Director DIN 10668954
DIN 10668954 First appointment Jun 2024 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shelly Batra

Data last updated:

Shelly Batra is a Director at Onealphamed Private Limited (since 2024). The company operates in Research & Development.

DIN 10668954
Primary Designation Director
Industry Research & Development
First Appointment 14 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Onealphamed Private Limited U73100HR2024PTC122553
Director14 Jun 20242024Active

Board colleagues of Shelly Batra

NameDINCompanyDesignation
Blessy Babychan10504533Onealphamed Private LimitedIndividual Subscriber
Sandeep Kumar Batra10668955Onealphamed Private LimitedDirector

Directorship timeline

Open interactive timeline →
Onealphamed Private Limited
Premium access

Shareholding and investment profile for Shelly Batra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shelly Batra

Shelly Batra currently holds 1 directorship: Onealphamed Private Limited (Director, since 14 Jun 2024).

Shelly Batra was first appointed on 14 Jun 2024 as Director at Onealphamed Private Limited.

The current boards of Shelly Batra's companies include Blessy Babychan (Onealphamed Private Limited), Sandeep Kumar Batra (Onealphamed Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available